FLUMETHASONE PIVALATE

SynDRA canonical compound SYN0023250 — structure-anchored drug synonym record

Clinical phase	Launched
Approval status	Approved · OTC
Primary target(s)	NR3C1
Mechanism of action	glucocorticoid receptor agonist
Indication	dermatitis
Disease area	Dermatology

All known targets

flumetasone pivalate
flumethasone 21-pivalate
locacorten
locorten
Flumetasone pivalate
Flumethasone 21-pivalate
NSC-107680
Locorten
Locorten-vioform
Locacorten
Lorinden
Flumethasone pivalate (USP)
KS-1138
Locorten (TN)
Flumetasone pivalate (JAN/BAN)
Lpha.-methylpregna-1,4-diene-3,20-dione 21-pivalate
[2-[(6S,8S,9R,10S,11S,13S,14S,16R,17R)-6,9-difluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] 2,2-dimethylpropanoate
6,9-Difluoro-11,17-dihydroxy-16-methyl-3,20-dioxopregna-1,4-dien-21-yl pivalate
6.Alpha.,9-Difluoro-11.beta.,17,21-trihydroxy-16.a
6.Alpha.,9.alpha.-Difluoro-16.alpha.-methylprednisolone 21-pivalate
6alpha,9-Difluoro-11beta,17,21-trihydroxy-16alpha-methylpregna-1,4-diene-3,20-dione 21-(2,2-dimethylpropionate)
6alpha,9-difluoro-11beta,17-dihydroxy-16alpha-methyl-3,20-dioxopregna-1,4-dien-21-yl 2,2-dimethylpropanoate
Flumethasone-21-pivalate
NSC 107680
0DV09X6F21
CHEBI:31620
NSC107680
DTXCID2028931
flumethasone dimethylpropionate
RefChem:55207
MLS000069558
MLS001077304
SMR000058824
C27H36F2O6
Flumetasone 21-pivalate
UNII-0DV09X6F21
Flumetasone pival